Skip to main content

and
  1. No Access

    Article

    A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation

    Intravenous immunoglobulin is approved for use in allogeneic bone marrow transplant recipients for prevention of graft-versus-host disease (GVHD) and infections, but the minimally effective dose has not been e...

    DJ Winston, JH Antin, SN Wolff, BE Bierer, T Small in Bone Marrow Transplantation (2001)

  2. No Access

    Article

    Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia

    Therapy-related myelodysplasia (MDS) is a fatal marrow disorder distinct from primary MDS. We examined the efficacy of bone marrow transplantation (BMT) as a treatment for patients with therapy-related MDS. Ei...

    KK Ballen, DG Gilliland, EC Guinan, C-C Hsieh, SK Parsons in Bone Marrow Transplantation (1997)

  3. No Access

    Article

    Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation

    Severe aplastic anemia (SAA) is a frequent complication of orthotopic liver transplantation for non-typeable viral hepatitis. Allogeneic bone marrow transplantation (BMT) may successfully reconstitute hematopo...

    NS Trede, AB Warwick, PM Rosoff, R Rohrer, BE Bierer in Bone Marrow Transplantation (1997)

  4. No Access

    Article

    Isolated testicular relapse in an adolescent 5 years following allogeneic bone marrow transplantation for acute myelogenous leukemia

    A case of isolated testicular relapse occurring 5 years after allogeneic bone marrow transplantation (BMT) for acute myelogenous leukemia (AML) is reported. The patient presented with M4 AML at age 13 and unde...

    LE Lehmann, EC Guinan, SL Halpern, MJ Donovan, BE Bierer in Bone Marrow Transplantation (1997)